Study finds hearing aids modestly slow cognitive decline in older adults with hearing loss
A two-year Chinese clinical trial tracked 703 older adults with both moderate-to-severe hearing loss and mild cognitive impairment, assigning half to receive hearing aids and half to receive health education. Participants using hearing aids showed a slightly lower rate of progression to dementia-level impairment compared to the control group, and demonstrated improvements in cognitive recovery scores. While the results are encouraging, researchers note that hearing aids have not yet proven to prevent dementia outright.
Age-related hearing loss, known as presbycusis, affects a substantial portion of the elderly population due to deterioration within the inner ear structures. The connection between untreated hearing loss and cognitive decline has emerged as an area of scientific interest, with hearing loss identified as a modifiable risk factor potentially responsible for millions of dementia cases globally, particularly in lower-income regions where prevalence estimates are higher.
The CHOICE trial distinguished itself from prior research by specifically recruiting participants already experiencing mild cognitive impairment, rather than cognitively healthy individuals. This targeted approach allowed researchers to observe measurable differences in progression rates between treatment and control groups over the two-year period, whereas previous studies found minimal observable change in populations with normal cognition.
This research could influence clinical approaches to managing older adults at risk for cognitive decline, potentially expanding hearing aid prescription beyond purely audiological indications. If findings prove reproducible across diverse populations, healthcare systems may consider hearing aid provision as part of dementia prevention strategies. However, the modest effect size and geographic specificity of the trial suggest caution; broader implementation would require additional evidence and careful consideration of accessibility, cost, and which populations might benefit most.